BIO-FD&C Co.,Ltd. (KOSDAQ:251120)
South Korea · Delayed Price · Currency is KRW 8,210.00
-160.00 (-1.91%)
At close: Jul 20, 2026
BIO-FD&C Market Cap
BIO-FD&C has a market cap or net worth of 69.57 billion as of July 21, 2026. Its market cap has decreased by -59.53% in one year.
Market Cap
69.57B
Enterprise Value
16.16B
Revenue
18.85B
Ranking
n/a
PE Ratio
11.02
Stock Price
8,210.00
ChartMarket Cap Chart
Since February 21, 2022, BIO-FD&C's market cap has decreased from 193.04B to 69.57B, a decrease of -63.96%. That is a compound annual growth rate of -20.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 69.57B | -49.37% |
| Dec 30, 2025 | 137.39B | 14.33% |
| Dec 30, 2024 | 120.17B | -2.12% |
| Dec 28, 2023 | 122.78B | -16.94% |
| Dec 29, 2022 | 147.83B | -23.42% |
| Feb 21, 2022 | 193.04B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CORESTEMCHEMON | 77.81B |
| SunBio,Inc. | 69.75B |
| CTCBIO | 68.26B |
| EyeGene | 64.84B |
| QuadMedicine | 64.53B |
| AriBioLab | 64.05B |
| PanGen Biotech | 62.10B |
| KoBioLabs | 60.98B |